VolitionRx Limited VNRX
0.16 USD 0.00 (-1.58%)
Regular-session close
0.16 0.00 -1.23%
After hours · Nov 20, 7:45 PM ET
0.1555 Day range 0.17
0.16 52-week range 7.00
- YTD
- -96.88%
- 1 year
- -97.54%
News
benzinga.com VolitionRx Highlights Diagnostic Licensing Talks, Cancer Detection Progress And Debt Reduction Of Over $5M Peer-reviewed validation in sepsis, >95% early-stage cancer detection in a blinded cohort, a government-funded sepsis program in France, licensing discussions with more than a dozen diagnostic…
prnewswire.com VolitionRx Highlights a Transformational Year: Clinical Validation, Commercial Partnerships, and Potential Upcoming Milestones Peer-reviewed validation in sepsis, >95% early-stage cancer detection in a blinded cohort, a government-funded sepsis program in France, licensing discussions with more than a dozen diagnostic…
prnewswire.com Volition Expands Contract with Fujifilm to Include the Nu.Q® Vet Test for Cats Expansion extends potential use of Nu.Q® technology to Japan's almost nine million cats Volition expects Nu.Q® Vet Feline Test to be the world's first simple, affordable blood-based liquid biopsy…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Akanda (NASDAQ:AKAN) shares increased by 55.1% to $2.11 during Monday's pre-market session. The market value of their outstanding shares is at $3.5 million. Alpha Tau Medical (NASDAQ:DRTS)…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers InflaRx (NASDAQ:IFRX) stock rose 12.7% to $1.32 during Friday's after-market session. The market value of their outstanding shares is at $182.6 million. Instinct Bio Technical Co…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Cerenome (NASDAQ:CNSY) shares rose 39.5% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $5.8 million. As per the press release, Q3 earnings came…benzinga.com VolitionRX Q3 EPS $(0.21) Beats $(0.40) Estimate, Sales $1.614M Beat $706.500K Estimate VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.40) by 47.5 percent. This is a 79 percent increase over losses of $(1.00) per…
benzinga.com VolitionRx Executes Non-Binding Letter Of Intent With Missionpharma A/S To Develop, Roll Out Volition's Prototype Lateral Flow Technology For NETosis VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has executed a non-binding Letter of Intent ("LOI") with Missionpharma A/S, a Danish global
benzinga.com VolitionRx Makes $500K Cash Partial Prepayment Towards Outstanding Principal Balance On Its Senior Secured Convertible Promissory Note Note dated January 15, 2026, in the original principal amount of $2,400,000 (the "Note"), issued to Lind Global Asset Management XII LLC ("Lind"). Following the partial pre-payment, the remaining
